A Molecular Dynamics Study of Amyloid-β (1-42) Peptide Dimer Formation on the Surface of Phospholipid Bilayers  by Davis, Charles H. & Berkowitz, Max L.
484a Tuesday, February 23, 2010Alzheimer’s Association, NIGMS, and the NIA for their financial support of
this work.
2506-Pos
The Interaction with b-Amyloid Impairs the Mechanical Stability of
Polymer Cushioned Membrane
C. Canale1, S. Dante1, R. Steitz2, T. Hauss2, N.A. Dencher3, A. Diaspro1.
1The Italian Institute of Technology, Nanophysics Department,
Genova, Italy, 2BENSC, Helmholtz Center, Berlin, Germany,
3TU, Darmstadt, Germany.
The mechanism of neurodegeneration caused by b-amyloid (Ab) in Alzheim-
er’s disease is still controversial. Neuronal toxicity is exerted mostly by various
species of soluble Ab oligomers. Recent data depict membranes as the main
sites where proteins/peptides are recruited and concentrated, misfold, and nu-
cleate amyloids; at the same time, membranes are considered key triggers of
amyloid toxicity.
We demonstrated the capability of Ab to penetrate and destabilize stacked lipid
bilayers in a previous work. In this study, in order to maintain the natural flu-
idity of the membrane, polymer cushioned lipid bilayers have been used as
a model for neuronal membrane. Layer-by-layer technique was used for the
fabrication of the polymer cushion of charged poly-electrolytes, the lipid mem-
brane is built on the polymer film by unilamellar vesicle fusion. Neutron reflec-
tivity was used to monitor the kinetics of adsorption of the lipid bilayer onto the
polymer surface; the conditions for the best surface coverage have been deter-
mined. The structure of the lipid bilayers is modified by the interaction with
Ab1-42; Neutron reflectivity showed a change of the scattering density profile
in the direction perpendicular to the membrane plane, suggesting penetration of
Ab in the double layer. Atomic force microscope (AFM) has been used to test
the lipid packing of the membrane through film rupture experiments and to
compare the bilayer morphology in the presence or in the absence of Ab. We
demonstrated that the presence of Ab weakens the lipid packing in the model
membranes.
We compared the results obtained on polymer cushioned lipid bilayers with
those obtained using a rigid substrate (freshly cleaved mica) for membrane
preparation.
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A hallmark of Alzheimer’s disease (AD) is the rearrangement of the b-amy-
loid (Ab) peptide to a non-native conformation that promotes the formation
of toxic, nanoscale aggregates. One of many potential pathways for Ab tox-
icity may be modulation of lipid membrane function on cellular surfaces.
There are five mutations clustered around the central hydrophobic core of
Ab near the a-secretase cleavage site (the A21G Flemish mutation, E22K
Italian mutation, E22G Arctic mutation, E22Q Dutch mutation and the
D23N Iowa mutation). These point mutations are associated with hereditary
diseases ranging from almost pure cerebral amyloid angiopathy (CAA) to
typical Alzheimer’s disease pathology with plaques and tangles. We hypoth-
esizethat these point mutations alter the Ab aggregation pathway and its in-
teraction with cellular lipid membranes, resulting in altered disease progres-
sion and phenotypes. Brain lipid extract was used to form bilayers that are
physiologically relevant models of neuronal cell surface. Intact lipid bilayers
are exposed to different mutant forms of Ab, and Atomic Force Microscopy
was used to follow the aggregation of Ab and membrane integrity over a 24
hour period. The goal of this study was to determine how point mutations in
Ab alter electrostatic interactions between the Ab and the lipid surface. These
interactions may affect aggregation, morphological characteristics, and bila-
yer disruption of Ab on the model lipid membranes which may play a role
in Ab-related toxicity.
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The Amyloid-b (Ab) peptide is an integral aggregate species in the progression
and neurotoxicity of Alzheimer’s disease. While Ab fibrils were historically
considered the toxic species in Alzheimer’s disease, recent evidence has shifted
the focus towards oligomers as the most dangerous aggregate structure for neu-
rons. In this aggregation process, the conversion of monomeric Ab into a dimer
constitutes the first step in oligomer formation. Further work has shown that
cell membranes may play a substantial role in promoting aggregation throughfacilitating the protein-protein interactions that drive aggregation. We have
used extensive replica exchange molecular dynamics simulations to demon-
strate that monomeric Ab does not adopt stable secondary structure over time-
scales that have allowed for significant structure formation in solution. Further,
to characterize dimer formation on the surface of a model lipid bilayer, we have
used a thermodynamic cycle to indirectly calculate free energies of dimeriza-
tion on the bilayer surface. Use of a thermodynamic cycle helps to decrease
bias due to initial conditions that would occur through directly calculating a di-
merization free energy. We have calculated the free energies of dimerization
for a preformed dimer containing a single antiparallel b-sheet or a pair of
b-hairpin monomers. While these structures are representative of predicted fi-
bril structures, comparison of dimerization free energies provides insight into
the effect of the bilayer on the dimerization process. We have found that the
bilayer does affect dimerization free energy depending on the dimer structure
and bilayer surface charge. Our work demonstrates that a lipid bilayer is able
to substantially hinder Ab monomer structure formation and influence Ab
dimer formation.
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In early atherogenesis, subendothelial retention of lipidic droplets is associated
with an inflammatory response-to-injury, culminating in the formation of foam
cells and plaque. Low density lipoprotein (LDL) is the main constituent of sub-
endothelial lipidic droplets. LDL can be sketched as an inner lipidic core sur-
rounded by a phospholipid monolayer, with the protein (apoB-100) wrapped
around the particles’ surface and partly seeping into the phospholipid mono-
layer and the inner cholesterol core.
We found that in a naturally occurring subpopulation of LDL (electronegative
LDL-), the apoB-100 is misfolded and is capable of triggering the formation of
aggregated, amyloid-like LDL structures. LDL- can be produced in human
plasma by secretory phospholipases A2.
Both protein misfolding and LDL amyloids can well represent modifications
able to transform this cholesterol carrier into a trigger for a response-to-injury
in the artery wall.
Furthermore, by using Small Angle X-ray Scattering we furnish further evi-
dences that the hormone 17-b-estradiol (E2) binds to a single highly specific
site in apoB-100 and stabilizes its structure, even if the formation of LDL- is
not altered by E2 binding. This results in an increased ellipticity of apoB-
100, an overall volume shrinkage with modifications both in the outer shell
and lipidic core, and an increased resistance to structural and conformational
loss. Notably, also the formation of LDL amyloid aggregates is hindered by E2.
Our findings converge to a picture where a possible explanation of the benefi-
cial effect of E2 in the protection against the vascular response-to-injury can
find its mechanism.
In addition, our results add arguments to the stringent lipid-protein structural
interplay in LDL, with modifications in lipids being paralleled with apoB-
100 structural and functional modifications, and vice versa.
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Increasing evidence implicates interactions between Abeta peptide and lipid in
the development of Alzheimer’s disease. More generally, Abeta peptide inter-
actions with membranes seem to depend on the composition of the lipid bilayer
and the structural features of the peptide. One key parameter should be pH since
one site of intracellular Abeta peptide production and/or accumulation is likely
to be endosomes. This intracellular endosomal accumulation was suggested to
contribute to disease progression.
In this workr, we report a study on the 11-22 amphiphilic domain of Abeta in
interaction with model membrane; this region contains most of the charged res-
idues of the N-terminal domain of Abeta. We show that the peptide charge, and
more precisely the protonation state of histidines 13 and/or 14 is important for
the interaction with lipids. Hence, it is only at endosomal pH that a conforma-
tional change of the peptide is observed in the presence of negatively charged
lipid vesicles, i.e. when both lipid headgroups and histidines can interact
through electrostatic interactions. Specific interactions of the fragment with
phosphatidylserine and to a lesser extent with phosphatidylcholine, but not
